Hormonal regulation of PPARγ activity has been previously demonstrated in cases where PPARγ activity was stimulated by insulin treatment (40, 41), and furthermore, its overexpression led to hepatic steatosis (42). The gene discussed is INS; the disease is Hepatic steatosis.